![Highly portable quantitative screening test for prostate-specific antigen at point of care - ScienceDirect Highly portable quantitative screening test for prostate-specific antigen at point of care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590262821000332-ga1.jpg)
Highly portable quantitative screening test for prostate-specific antigen at point of care - ScienceDirect
![Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/812a8c8b-672b-4364-bbae-980999722fbe/mtbl001.jpg)
Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![PSA genotypes and serum PSA levels (log- transformed) in prostate cancer | Download Scientific Diagram PSA genotypes and serum PSA levels (log- transformed) in prostate cancer | Download Scientific Diagram](https://www.researchgate.net/publication/262265945/figure/tbl1/AS:203005845610497@1425411773110/PSA-genotypes-and-serum-PSA-levels-log-transformed-in-prostate-cancer.png)
PSA genotypes and serum PSA levels (log- transformed) in prostate cancer | Download Scientific Diagram
18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study | PLOS ONE
![PSA serum level changes in the study groups [* significant difference... | Download Scientific Diagram PSA serum level changes in the study groups [* significant difference... | Download Scientific Diagram](https://www.researchgate.net/publication/357723076/figure/fig1/AS:1116475268038662@1643199855280/PSA-serum-level-changes-in-the-study-groups-significant-difference-compared-to-pretest.png)
PSA serum level changes in the study groups [* significant difference... | Download Scientific Diagram
![Efficacy of Prostate-Specific Antigen to Categorize Men with Prostate Pathology into Benign, Premalignant, and Malignant Lesions Efficacy of Prostate-Specific Antigen to Categorize Men with Prostate Pathology into Benign, Premalignant, and Malignant Lesions](https://sciresol.s3.us-east-2.amazonaws.com/srs-j/jmsh/images/front-images/37a06e4a72d6cb27621f1ed829bbee81.jpg)